Valiant Laboratories (NSE:VALIANTLAB) Interest Expense : ₹-1 Mil (TTM As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Valiant Laboratories Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Valiant Laboratories's interest expense for the three months ended in Dec. 2024 was ₹ -1 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₹-1 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Valiant Laboratories's Operating Income for the three months ended in Dec. 2024 was ₹ 1 Mil. Valiant Laboratories's Interest Expense for the three months ended in Dec. 2024 was ₹ -1 Mil. Valiant Laboratories's Interest Coverage for the quarter that ended in Dec. 2024 was 1.65. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Valiant Laboratories Interest Expense Historical Data

The historical data trend for Valiant Laboratories's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valiant Laboratories Interest Expense Chart

Valiant Laboratories Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Interest Expense

-17.84

-0.73

-2.54

-0.78

Valiant Laboratories Quarterly Data
	Mar21	Mar22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial							-0.19	-0.21	-0.53	-0.06	-0.62

Valiant Laboratories Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-1 Mil.

Valiant Laboratories (NSE:VALIANTLAB) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Valiant Laboratories's Interest Expense for the three months ended in Dec. 2024 was ₹-1 Mil. Its Operating Income for the three months ended in Dec. 2024 was ₹1 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was ₹0 Mil.

Valiant Laboratories's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2024 )	/	Interest Expense (Q: Dec. 2024 )
	=	-1	*	1.021	/	-0.619
	=	1.65

The higher the ratio, the stronger the company's financial strength is.

Valiant Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valiant Laboratories Ltd (NSE:VALIANTLAB) » Definitions » Interest Expense

Traded in Other Exchanges

543998:India

Address

Mulund Goregaon Link Road, 104, Udyog Kshetra, Mulund, MH, IND, 400080

Website

https://www.valiantlabs.in

Valiant Laboratories Ltd is an Active Pharmaceutical Ingredient (API)/Bulk Drug manufacturing company with having focus on manufacturing Paracetamol. Paracetamol is one of the widely used analgesics globally and is recommended as the first-line therapy in pain conditions by the World Health Organization. Paracetamol has several applications such as usage in the treatment of headaches, muscle aches, arthritis, backaches, toothaches, colds, and fever. It manufactures Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of its customers.

Valiant Laboratories Headlines

No Headlines